Translational medicine: Path to personalized and public health

Biomarkers in Medicine

Volumn 4, Issue 6, 2010, Pages 787-790

  Terzic, Andre ^a   Waldman, Scott A ^b  

^a MAYO CLINIC   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

individualized medicine; personalized medicine; team science; translational medicine

Indexed keywords

BIOLOGICAL MARKER;

CLINICAL PRACTICE; EVIDENCE BASED MEDICINE; HEALTH CARE DELIVERY; HEALTH CARE QUALITY; HUMAN; INDIVIDUALIZATION; MEDICAL DECISION MAKING; MEDICAL RESEARCH; PATIENT CARE; PERSONALIZED MEDICINE; PREDICTION; PROGNOSIS; PUBLIC HEALTH SERVICE; REGENERATIVE MEDICINE; REVIEW; TRANSLATIONAL RESEARCH; TREATMENT OUTCOME;

ALGORITHMS; COOPERATIVE BEHAVIOR; EVIDENCE-BASED MEDICINE; HUMANS; INDIVIDUALIZED MEDICINE; INTERDISCIPLINARY COMMUNICATION; PUBLIC HEALTH; REGENERATIVE MEDICINE; SOCIAL PROBLEMS; TRANSLATIONAL RESEARCH;

EID: 78650717943     PISSN: 17520363     EISSN: None     Source Type: Journal    
DOI: 10.2217/bmm.10.101     Document Type: Review

References (17)

1. Feero WG, Guttmacher AE, Collins FS: Genomic medicine - an updated primer. N. Engl. J. Med. 362, 2001-2011 (2010).
2. Waldman SA, Terzic A: Molecular therapeutics from knowledge to delivery. Clin. Pharmacol. Ther. 87, 619-623 (2010).
3. Hamburg MA, Collins FS: The path to personalized medicine. N. Engl. J. Med. 363, 301-304 (2010).
4. Waldman SA, Kraft WK, Nelson TJ, Terzic A: Clinical pharmacology: a paradigm for individualized medicine. Biomark. Med. 3, 679-684 (2009).
5. Arrell DK, Terzic A: Network systems biology for drug discovery. Clin. Pharmacol. Ther. 88, 120-125 (2010).
6. Terzic A, Perez-Terzic C: Channelopathies: decoding disease pathogenesis. Sci. Transl. Med. 2, 42ps37 (2010).
7. Waldman SA, Terzic A: Translational medicine in the era of health care reform. Clin. Transl. Sci. 2, 96-97 (2009).
8. Waldman SA, Terzic A: Clinical and translational science: from bench-bedside to global village. Clin. Transl. Sci. 3(5), 254-257 (2010).
9. Terzic A, Nelson TJ: Regenerative medicine advancing health care 2020. J. Am. Coll. Cardiol. 55(20), 2254-2257 (2010).
10. Nelson TJ, Behfar A, Terzic A: Strategies for therapeutic repair: the 'R3' regenerative medicine paradigm. Clin. Transl. Sci. 1, 168-171 (2008).
11. Nelson TJ, Behfar A, Terzic A: Stem cells: biologics for regeneration. Clin. Pharmacol. Ther. 84(5), 620-623 (2008).
12. Nelson TJ, Behfar A, Yamada S, Martinez-Fernandez A, Terzic A: Stem cell platforms for regenerative medicine. Clin. Transl. Sci. 2(3), 222-227 (2009).
13. Cortese DA: A vision of individualized medicine in the context of global health. Clin. Pharmacol. Ther. 82, 491-493 (2007).
14. Waldman SA, Terzic A: Pharmacoeconomics in the era of individualized medicine. Clin. Pharmacol. Ther. 84, 179-182 (2008).
15. Khoury MJ, Gwinn M, Yoon PW, Dowling N, Moore CA, Bradley L: The continuum of translation research in genomic medicine: how can we accelerate the appropriate integration of human genome discoveries into health care and disease prevention? Genet. Med. 9, 665-674 (2007).
16. Brook RH: Medical leadership in an increasingly complex world. JAMA 304, 465-466 (2010).
17. Kon AA: The Clinical and Translational Science Award (CTSA) Consortium and the translational research model. Am. J. Bioeth. 8, 58-60 (2008).